Concepedia

Zi Yu

ZY

Statistics

Publications

3

Citations

95

H-Index

3

Active since

2018

Affiliations

China Medical University(Current)

First Hospital of China Medical University

Liaoning Cancer Hospital & Institute

Zi Yu is an author at China Medical University specializing in cancer biology, tumor biology, and medicine.

Top concepts

Publications per year

2018–2019

3

Publications

3

ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway

Gejun Zhang, Zi Yu, Shui Fu et al. · Cancer Gene Therapy · 2018 · 44 citations

, , +6

PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway

Chengcheng Lv, Shui Fu, Qingzhuo Dong et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 39 citations · Full text

PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathways

Zi Yu, Qiang Li, Gejun Zhang et al. · International Journal of Oncology · 2019 · 12 citations · Full text

, , +19

1–3 of 3